跳至主要内容
临床试验/JPRN-UMIN000016085
JPRN-UMIN000016085已完成未知

Phase I study of the preventive effect of Kampo medicine on oxaliplatin-induced peripheral neurotoxicity - The preventive effect of Kampo medicine on oxaliplatin-induced peripheral neurotoxicity

Wakayama Medical University, School of Medicine0 个研究点目标入组 18 人开始时间: 2014年12月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.having resistance for using Kampo 2. chemotherapy using oxaliplatin has been performed 3.having double cancer 4.having serious sensory disturbance 5.having serious drug hypersensitivity 6. having serious infection 7. having serious psycho-neurologic disease 8.having serious complication as follows: uncontrorable diabetes mellitus, uncontrorable hypertension, interstitial pneumonia or pulmonary fibrosis, ileus, and serious heart disease 9. inappropriate judgment for study by clinical investigator

研究者

发起方
Wakayama Medical University, School of Medicine

相似试验

Phase I study of the preventive effect of Kampo... | 临床试验